Healthy Subjects or Volunteers
6
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Trigger Point Dry Needling With and Without Electrical Stimulation in Healthy Subjects
Dynamic Measurement of Cerebrospinal Fluid in Healthy Subjects: Pilot Study
Training and Testing Database for IMU Based Gait Analysis Methods
Hydrogen-Rich Water and Resting Metabolism in Young Adults
Investigating the Impact of Afferent Stimulation on Proprioceptive Function in Post-Stroke Rehabilitation
A Study of Tralokinumab When Delivered Subcutaneously at Different Flow Rates to Healthy Volunteers